Vasan et al. examined the PIK3CA-mutant cancer genomes and reported that 12–15% of breast cancers and other tumor types harbor multiple PIK3CA mutations, the majority of which (95%) are double mutations29. This evidence concerns the gene PIK3CA and breast cancer.